Silent Twiddler syndrome despite dual-anchor fixation in deep brain stimulation: two case reports
Evolution of brain-computer interface technologies for stroke rehabilitation: a bibliometric integration of neural decoding and functional recovery (2016–2025)
Latent profile analysis and associated factors of alexithymia among patients with chronic obstructive pulmonary disease
Factors associated with unmet psychological care needs and development of a Neuman systems model-based risk prediction model in patients with hepatocellular carcinoma
The ECHO study: compassion-focused therapy for young voice hearers and their caregivers. A pilot study
Engineered ADARs enable precision A-to-G base editing of DNA
Nature Biotechnology, Published online: 10 July 2026; doi:10.1038/s41587-026-03223-z
Bystander edits are minimized by engineering an adenosine deaminase acting on RNA for DNA base editing.
Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition
Nature Biotechnology, Published online: 10 July 2026; doi:10.1038/s41587-026-03227-9
In vivo cytosine base editing is made efficient with potent glycosylase inhibition.
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial
Nature Medicine, Published online: 10 July 2026; doi:10.1038/s41591-026-04475-7
In a non-randomized phase 1 trial, patients with recurrent glioblastoma received anti-LAG-3 relatlimab with or without anti-PD-1 nivolumab, showing that both monotherapy and combination therapy are safe and result in encouraging preliminary clinical response signals.
Health system learning enables generalist neuroimaging models
Nature Medicine, Published online: 10 July 2026; doi:10.1038/s41591-026-04497-1
NeuroVFM, trained on routine health system MRI and CT scans, learns general neuroimaging representations that improve diagnosis, report generation and triage, showing how private clinical data will power safer, more accurate medical AI.

